Digital Pharma: Pharma iPhone app update
pharmafile | October 15, 2010 | News story | Medical Communications | Astellas, Boehringer, Digital Pharma blog, GlaxoSmithKline, Lundbeck, Menarini, Nycomed, Pfizer, Servier, Teva, app, iphone
The ranks of pharma iPhone apps are increasing all the time and recent months have seen new additions from Teva, Astellas, Nycomed, Pfizer and GlaxoSmithKline.
Teva’s Puff-o-meter app aims to help UK asthma patients keep track of how many puffs are left in their inhaler and was produced by recently-launched digital agency Sublime Digital.
It provides a reminder five-days before the inhaler is due to run out, with notifications to the patient to renew their prescription as the ‘running low’ mark approaches.
Another respiratory app comes from Nycomed, which has partnered with Doctot and provided the Irish company with an unrestricted educational grant to develop its COPD app.
Nycomed’s interest in the area is currently focused on the COPD treatment Daxas, which it is in the process of launching in Europe with Merck Sharpe & Dohme and the UK is one of its first markets.
The COPD iPhone app provides a suite of the most widely used clinician-administered assessment scales and tables related to COPD patients, including interactive scales for:
• BODE Index (BMI, Obstruction, Dyspnoea, Exercise)
• ADO (Age, Dyspnoea, Obstruction)
• Goldman Cardiac Risk Index (GCR)
• Modified MRC Dyspnoea Scale (MMRC)
• Charleson Comorbidity Index (CCI) - Wells Score for DVT Risk
Doctot is a partnership between medical and technical firm Clinisynergy and creative agency Tricycle Interactive.
The other pharma iPhone apps they’ve worked on – again via unrestricted educational grants – are the Pain (for Nycomed), Depression (Servier), Stroke (Menarini) and Geriatric apps (Lundbeck), plus the NIHSS app – also for stroke (Boehringer Ingelheim).
Elsewhere in pharma app-land, Pfizer and GlaxoSmithKline are jointly supporting the world’s first meningitis signs and symptom app from UK patient group the Meningitis Trust.
The Trust’s chief executive Sue Davie explains in the following video why they produced an iPhone app and the progression it marks from their traditional ‘symptom checker’ cards.
Meningitis Trust iPhone app from Meningitis Trust on Vimeo.
Finally Astellas recently produced a cardiac imaging test app for US physicians and worked with comms agency Photosound on the Get Bladder Fit app for the public, and lastly Pfizer launched Smidge, a Canadian health living app for the general public.
Dominic Tyer is web editor for Pharmafocus and InPharm.com and the author of the Digital Pharma blog He can be contacted via email, Twitter or LinkedIn.
Related Content
Teva announces positive results from trial of AJOVY for migraine
Teva has announced positive results from the phase 4 PEARL study of AJOVY (fremanezumab), its …
BioMed X and Servier launch Europe’s first XSeed Labs to advance AI-powered antibody design
BioMed X and Servier have announced the launch of Europe’s first XSeed Labs research project, …
NICE recommends Pfizer’s new once-weekly treatment for haemophilia B on NHS
Walton Oaks, 21st May 2025 – Pfizer Ltd announced today that the National Institute for Health and Care …
